Navigation Links
Drug therapy for allergy moves forward
Date:5/12/2014

Researchers have identified several target molecules which are suitable for the development of new allergy drugs. The Journal of Allergy and Clinical Immunology, the most prestigious journal in the field of allergology, has recently published an extensive review article on the prospects of drug therapy for allergy. Completed in a large-scale EU project, the lead author of the review article is Professor Ilkka Harvima of the University of Eastern Finland and Kuopio University Hospital.

Immediate allergic reactions and allergic diseases such as allergic rhinitis, asthma and urticaria are extremely widespread in the population. Traditionally, drug therapy for allergy is based on the use of non-sedative antihistamines, i.e. blocking of the histamine H1 receptors, but sometimes additional help is obtained from blockers of the cysteinyl leukotriene receptor-1.

Antihistamines seek to prevent allergic symptoms caused by histamine released by mast cells. Mast cells, also known as "allergy cells", are cells of the immune system which become activated by environmental allergens.

"However, even high doses of H1 antihistamine drugs aren't enough to alleviate the symptoms of some patients. This is understandable, as when the mast cell becomes activated, several other strong mediators besides histamine get released, too. Histamine can also affect other receptors of the cell surface than the H1 receptor," Professor Harvima explains.

Over the past years, researchers have identified several mast cell molecules which can be targets of new drugs. Several of these have already proceeded to clinical trials. These targets include, for example, serine proteinases tryptase, chymase, cathepsin G, which are enzymes that break down proteins, as well as 5-lipoxygenase-activating protein FLAP, 15-lipoxygenase-1, prostaglandin-D2, and proinflammatory cytokines such as TNF-alpha, IL-4, IL-6 and IL-17. New drugs targeting the histamine H4 receptor are
'/>"/>

Contact: Ilkka Harvima
ilkka.harvima@kuh.fi
358-447-172-875
University of Eastern Finland
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Two-lock box delivers cancer therapy
2. WHI reports $37.1B economic return on combined hormone therapy clinical trial
3. Study finds family-based exposure therapy effective treatment for young children with OCD
4. No credible evidence to support cardiac risk of testosterone therapy
5. Outcomes of steroid therapy following surgery for infants with bile duct disorder
6. New combination therapy developed for multiple myeloma
7. New model can predict therapy outcomes in prostate cancer with bone metastasis
8. Stress research in therapy dogs reveals animals needs
9. Receiving chemotherapy after a breast cancer diagnosis may affect a patients employment
10. ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer
11. Massage therapy improves circulation, eases muscle soreness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... The LIV Fertility ... fertility preservation and deciding the right age to pursue egg freezing. Statistics show that ... age of 35 — a 150 percent increase since the 1970s. , Sadly, for ...
(Date:6/30/2015)... ... June 30, 2015 , ... The American Lung Association in California announced its ... San Diego. Speakers and clean air advocates included San Diego County Supervisor Ron Roberts, ... Hospital, and Daniel Sullivan, founder and president of Sullivan Solar Power. , For ...
(Date:6/30/2015)... ... June 30, 2015 , ... ADVOCATE, the premier provider ... awarded the exclusive billing agreements with Jackson Radiology Associates in Jackson, TN. ... proprietary suite of billing process software functionality called Experience Based Technology (EBTTM). ...
(Date:6/30/2015)... Long Beach, CA (PRWEB) , ... June 30, 2015 , ... ... Sea Skilled Nursing”, which features multiple patient and family member testimonials. Medicare rated the ... the country. Broadway plans to use the video to give future patients a firsthand ...
(Date:6/30/2015)... ... 2015 , ... Family and professional dementia caregivers are invited ... 9, 2015 at the Hyatt Regency Denver Tech Center from 7:30 am-4:30 pm. ... Campbell, the wife and daughter of singer Glen Campbell, who will discuss their ...
Breaking Medicine News(10 mins):Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 4Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 5Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:Family of Singer Glen Campbell to Discuss Living with Dementia at the Alzheimer's Association of Colorado's 26th Annual Education Symposium 2
... pigeon racing, bird shows, and falconry events is coming to an ... avian flu’s lethal strain was // detected in Eastern Europe. The ... and the death of several million birds. ,The ... in the country. The veterinary risk assessment led to the ban ...
... Peninsula Medical School has revealed that there is no evidence ... loses ? 2 billion by way of lost wages as ... was published in the British Medical Journal recommends moderation while ... propranolol, a yeast based product, tropisetron, fructose, tolfenamic acid, artichoke, ...
... is presumed that this year it is early and different from ... flu case increased greatly in number when compared to the previous ... reports to the press that they've had 4 cases of Influenza ... Prevention in Atlanta cautions the need for vaccines against this particular ...
... if you are a white senior citizen, says a ... over 2,000 black and white men and women aged ... a questionnaire to determine how much magnesium they were ... published in the Journal of the American Geriatrics Society., ...
... no matter how old they get, never lose their beauty - ... ~Martin Buxbaum, ,Jacqueline Saburido was a very normal girl who ... A tragic incident that occurred on the 19th of September 1999 ... which more than 60% of her body was burnt. She lost ...
... France have successfully operated on 15-month-old twins Mohamed and Souleymane, ... is the first operation of its kind in France. // ... follows in the steps of similar operations in Britain, South ... neurosurgery division of the La Timone hospital said that at ...
Cached Medicine News:Health News:The Looming Controversy Surrounding Facial Transplant 2
(Date:6/30/2015)... PAUL, Minn. , June 30, 2015  EnteroMedics ... of devices that use neuroblocking technology to treat obesity, ... of its previously announced public offering  of 40,229,886 units. ... 0.50 of a Series A warrant to purchase one ... B warrant to purchase one share of common stock, ...
(Date:6/30/2015)... BERKELEY, Calif. and ... CMC Biologics, Inc. , a global leader in ... therapeutic proteins, announced today that, as part of its ... expansion of its North American manufacturing facility in ... a single-use Bioreactor 6Pack™ facility.  The Bioreactor 6Pack™ configuration ...
(Date:6/29/2015)... 2015 Mordor Intelligence presents their ... Material (Plastic, Glass, Paper, Metal) - ByType of Packaging (Ampules, ... Tubes, Vials, Sachets) - By Geographical Region ( North ... Asia Pacific , Latin America , ... ) - discussing Industry Value Chain Analysis, Porter,s 5 ...
Breaking Medicine Technology:EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3CMC Biologics Expands GMP Manufacturing Capacity in the United States 2CMC Biologics Expands GMP Manufacturing Capacity in the United States 3Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 2Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 3
... PRINCETON, N.J., Jan. 4, 2011 Pharmasset, Inc. (Nasdaq: ... 29th Annual J.P. Morgan Healthcare Conference to be held January ... CA. Schaefer Price, President and Chief Executive Officer, will provide ... at 9:00 AM (PT). To access a simultaneous ...
... Jan. 4, 2011 Boston Scientific Corporation (NYSE: ... M.D., Chief Medical Officer, Cardiac Rhythm Management, on an article ... the American Medical Association .  The article reported on a ... received an implantable cardioverter defibrillator (ICD) did not meet evidence-based ...
Cached Medicine Technology:Pharmasset to Present at the 29th Annual J.P. Morgan Healthcare Conference 2Pharmasset to Present at the 29th Annual J.P. Morgan Healthcare Conference 3Statement of Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, Boston Scientific on JAMA Article 2
5.5 mm disk shape burr. Diamond coated tip. Use with E0824 B handle....
5.5 mm disk shape burr. Diamond coated tip. Use with E0824 B handle....
Short 12 mm taper with needle type tip. Stainless steel. Round smooth handle with polished finish. Overall length: 2.8 inches....
Taper with blunt tip. Stainless steel. Round knurled handle with polished finish. Taper : Long 32 mm. Overall length: 3.9 inches. Most popular size or model....
Medicine Products: